Johnson & Johnson
Swanson James D. Files Johnson & Johnson (JNJ) Form 4 - February 13, 2026
Transactions
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Swanson James D. | 2026-02-17 | Sell | 20.5K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-17 | Sell | 20.5K | $242.70 | $5.0M | Direct |
| Swanson James D. | 2026-02-17 | Buy | 20.5K | $164.62 | $3.4M | Direct |
| Swanson James D. | 2026-02-15 | Buy | 19.4K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-15 | Sell | 309 | $243.45 | $75.2K | Direct |
| Swanson James D. | 2026-02-15 | Buy | 1.4K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-15 | Sell | 492 | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-15 | Sell | 709 | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-15 | Sell | 214 | $243.45 | $52.1K | Direct |
| Swanson James D. | 2026-02-15 | Buy | 492 | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-15 | Buy | 709 | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Buy | 19.4K | $165.89 | $3.2M | Direct |
| Swanson James D. | 2026-02-13 | Sell | 143 | $244.55 | $35.0K | Direct |
| Swanson James D. | 2026-02-13 | Buy | 9.4K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Sell | 3.5K | $244.55 | $867.4K | Direct |
| Swanson James D. | 2026-02-13 | Buy | 447 | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Sell | 447 | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Sell | 9.4K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Sell | 19.4K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Sell | 22.2K | $0.00 | $0.00 | Direct |
| Swanson James D. | 2026-02-13 | Sell | 19.4K | $243.76 | $4.7M | Direct |
| Swanson James D. | 2026-02-13 | Buy | 22.2K | $162.75 | $3.6M | Direct |
| Swanson James D. | 2026-02-13 | Sell | 22.2K | $243.71 | $5.4M | Direct |
Profitelligence Alerts
Track JNJ insider activity
Get alerts when Johnson & Johnson executives trade their shares.
Advertisement
About Johnson & Johnson
Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
Official SEC Documents
Advertisement